Clinical trial
Safety and Efficacy of LR08 in Modulating Gut Microbiota and Improving Metabolic Health in Healthy Adults: A Clinical Study
NCT06875362 is registered in ClinicalTrials.gov with Wecare Probiotics Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of LR08 in Modulating Gut Microbiota and Improving Metabolic Health in Healthy Adults: A Clinical Study
- Lead sponsor
- Wecare Probiotics Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 10, 2025
- Completion date
- June 30, 2025
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy adults